Last news
LG Display Unveils 4th-Generation OLED Panel Optimized for AI Era

LG Display Unveils 4th-Generation OLED Panel Optimized for AI Era

SEOUL, South Korea, Jan. 16, 2025 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, continues to lead the way in large-sized OLED technology by unveiling its fourth-generation OLED TV panel. 33% brighter than the...

Shanghai opens its doors to foreign-owned hospitals

Shanghai opens its doors to foreign-owned hospitals

SHANGHAI, Jan. 16, 2025 /PRNewswire/ -- A news report from english.shanghai.gov.cn Shanghai announced on Jan 8 plans to encourage the establishment of wholly foreign-owned hospitals in the municipality's key economic zones, biopharmaceutical...

CDNetworks to Showcase Innovative Gaming Solutions at ICE 2025

CDNetworks to Showcase Innovative Gaming Solutions at ICE 2025

SINGAPORE and BARCELONA, Spain, Jan. 16, 2025 /PRNewswire/ -- CDNetworks, the APAC-leading network to deliver edge as a service, will present its latest gaming solutions at ICE 2025 in Barcelona, Spain on 20th – 22nd January. At the event, the...

Daon Expands Presence in Japan as part of ELEMENTS' acquisition of Polarify

Daon Expands Presence in Japan as part of ELEMENTS' acquisition of Polarify

ELEMENTS Inc., Japan, and Daon Inc. announce a long-term agreement to collaborate on identity assurance solutions TOKYO, Jan. 16, 2025 /PRNewswire/ -- Daon®, the Digital Identity Trust company, has announced a strategic partnership with ELEMENTS,...

(Taiwan) CMU Healthcare System and Nobel Laureate Randy Schekman Drive New Frontiers in Exosome Technology

(Taiwan) CMU Healthcare System and Nobel Laureate Randy Schekman Drive New Frontiers in Exosome Technology

TAICHUNG, Jan. 16, 2025 /PRNewswire/ -- On November 2, 2024, China Medical University (CMU) and Healthcare System hosted the International Forum of Extracellular Vesicles Technology and Novel Therapeutics to highlight Taiwan's advancements and...

Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer

Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer

SAN FRANCISCO and SUZHOU, China, Jan. 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...

Hurom Secures Victory in Korea Trade Commission Case Against NUC (Kuvings)

Hurom Secures Victory in Korea Trade Commission Case Against NUC (Kuvings)

NUC Found Guilty of Patent Infringement, Ordered to Cease Activities, Pay Fines SEOUL, South Korea, Jan. 16, 2025 /PRNewswire/ -- Hurom, the pioneer of low-speed masticating juicers and a global market leader, has successfully proven patent...

Ridgewood Infrastructure Announced $1.2 Billion Final Close for Fund II, Significantly Surpassing Its Target

Ridgewood Infrastructure Announced $1.2 Billion Final Close for Fund II, Significantly Surpassing Its Target

NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Ridgewood Infrastructure ("Ridgewood"), a leading investor in essential infrastructure in the U.S. lower middle market, today announced the final close of its second fund, Ridgewood Water & Strategic...

menu
menu